Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour second dose of Wegovy is taken one week after your first injection of 0.25 mg, at the same day and time you chose to begin. That weekly rhythm stays consistent throughout treatment — same day, roughly the same time, rotating injection sites as your prescriber has advised. Wegovy is a prescription-only medicine, and how you progress through the dosing schedule is always a clinical decision made with your prescriber, not something to adjust independently. The information below walks through the practical detail of that second injection and what the weeks around it typically look like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The mechanics of the second injection are identical to the first. You'll use a new pre-filled Wegovy pen at the 0.25 mg strength, injecting into the fatty tissue of your abdomen, thigh or upper arm. Rotating the exact spot within that area each week reduces the chance of skin irritation at the site. The full guide to Wegovy covers the pen technique in more detail if you want a refresher before you begin.
Timing matters in a straightforward way: pick the same day of the week you used for your first dose and stick to it. Some people anchor it to something predictable, a Sunday morning routine, for instance, before the kettle has boiled. That consistency makes it easier to build the habit and harder to accidentally skip a week. If your chosen day shifts by a day occasionally, that is usually fine, but your Patient Information Leaflet and prescriber are the right people to guide you on the exact flexibility window. Our page on what to do if a Wegovy dose is late covers the missed-dose rules in plain terms.
Storage between doses is straightforward: keep unused pens refrigerated at 2–8°C. The used pen from week one should go into a sharps container; never recap or reuse it.
For many people, the second dose is where the treatment starts to feel more real. The first injection can pass with little obvious effect; the second is sometimes when mild nausea, loose stools or a reduced appetite first appear. This is not a sign that something has gone wrong. Wegovy works as a GLP-1 receptor agonist, slowing gastric emptying and influencing appetite signals in the brain, and the gastrointestinal system sometimes needs a few weeks to adjust to that shift.
The NHS semaglutide medicines page lists the common side effects (nausea, diarrhoea, constipation, indigestion, headache and fatigue appear most often) and notes that they are typically mild to moderate and often ease within the first couple of weeks. Most people find that eating smaller portions, avoiding very fatty or rich meals and staying well hydrated takes the edge off. Our dedicated page on side effects around the second Wegovy dose goes into this in more depth.
Seek urgent medical attention if you develop severe, persistent abdominal pain that radiates to your back, with or without vomiting. The MHRA has highlighted acute pancreatitis as a known, though infrequent, serious side effect of GLP-1 medicines, you can report any suspected side effect directly at yellowcard.mhra.gov.uk.
Not immediately, and usually not for a few weeks yet. The standard Wegovy schedule begins at 0.25 mg for the first four weeks, so your second injection, and your third and fourth, are all at this starting level. The 0.25 mg dose exists to help your body settle into treatment rather than to produce significant weight loss; most of the clinical work happens at the higher maintenance doses reached later in the titration schedule.
After four weeks at 0.25 mg, the next step is typically 0.5 mg, then 1.0 mg, 1.7 mg and eventually the standard 2.4 mg maintenance dose, though how quickly you move through those steps depends entirely on how you are tolerating each level. Your prescriber reviews this before any change is made. The Wegovy doses guide explains the full schedule and what each phase is designed to achieve. It is also worth knowing that how you take each Wegovy dose stays consistent in technique even as the strength increases.
If you are curious about how private treatment costs work as you progress, the Wegovy price comparison guide for the UK sets out what to look for and what a transparent, all-in price should include.
Side effects that are severe, that do not ease after the first week or two, or that are affecting your ability to eat or drink properly are worth raising promptly. The same goes for any uncertainty about whether you have taken your dose correctly, whether you have accidentally injected into the wrong area, or whether you have stored your pens properly. These are not trivial questions, they affect how well treatment works and whether it is safe to continue at the current level.
At nume, a real clinician reviews every consultation and every repeat order. There is no algorithm deciding whether to progress your dose. If something about the second injection feels off, or you are not sure about the 0.25 mg starting phase, speaking to our clinical team directly is the right move. You can also read more about the team behind the service on the clinical team page. For questions that are less urgent, our FAQs cover a lot of the ground our prescribers hear most often.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.